Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-07-05
2011-11-15
Kaushal, Sumesh (Department: 1633)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C424S093100, C424S093200, C435S069100, C435S069400, C435S320100, C435S325000, C435S455000
Reexamination Certificate
active
08058253
ABSTRACT:
This invention is related to compositions and methods for decreasing cholesterol levels in a subject. The method utilizes a nucleic acid expression construct that encodes a growth-hormone-releasing-hormone (“GHRH”) that is delivered into a tissue of the subject, wherein, GHRH is expressed in vivo in the subject.
REFERENCES:
patent: 4223019 (1980-09-01), Momany et al.
patent: 4223020 (1980-09-01), Momany et al.
patent: 4223021 (1980-09-01), Momany et al.
patent: 4224316 (1980-09-01), Momany et al.
patent: 4226857 (1980-10-01), Momany et al.
patent: 4228156 (1980-10-01), Momany et al.
patent: 4228158 (1980-10-01), Momany et al.
patent: 4410512 (1983-10-01), Bowers et al.
patent: 4833166 (1989-05-01), Grosvenor et al.
patent: 4839344 (1989-06-01), Bowers et al.
patent: 5023322 (1991-06-01), Kovacs et al.
patent: 5036045 (1991-07-01), Thorner
patent: RE33699 (1991-09-01), Drengler
patent: 5061690 (1991-10-01), Kann et al.
patent: 5084442 (1992-01-01), Felix et al.
patent: 5134120 (1992-07-01), Boyd et al.
patent: 5137872 (1992-08-01), Seely et al.
patent: 5292721 (1994-03-01), Boyd et al.
patent: 5439440 (1995-08-01), Hofmann
patent: 5486505 (1996-01-01), Bowers et al.
patent: 5696089 (1997-12-01), Felix et al.
patent: 5702359 (1997-12-01), Hofmann et al.
patent: 5756264 (1998-05-01), Schwartz et al.
patent: 5776901 (1998-07-01), Bowers et al.
patent: 5792747 (1998-08-01), Schally et al.
patent: 5846936 (1998-12-01), Felix et al.
patent: 5847066 (1998-12-01), Coy et al.
patent: 2005/0004060 (2005-01-01), Draghia-Akli et al.
patent: 2005/0031549 (2005-02-01), Quay et al.
patent: 95/19805 (1995-07-01), None
patent: 96/12006 (1996-04-01), None
patent: 96/12520 (1996-05-01), None
patent: 97/07826 (1997-03-01), None
Montero et al, J. Mol. Endo. 25:157-168, 2000.
Acsadi, G., et al., Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs., Nature, Aug. 29, 1991;352(6338):815-8.
Ahn, C. W., et al, Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control, Clin Endocrinol (Oxf)., Apr. 2006;64(4):444-9.
Aihara, H., et al., Gene transfer into muscle by electroporation in vivo, Nat Biotechnol, Sep. 1998;16(9):867-70.
Akhtar, S., Non-viral cancer gene therapy: Beyond delivery, Gene Therapy (2006) 13, 739-740. doi:10.1038/sj.gt.3302692; published online Dec. 1, 2005.
Almendro, N., et al., Cloning of the human platelet endothelial cell adhesion molecule-1 promoter and its tissue-specific expression. Structural and functional characterization, J Immunol., Dec. 15, 1996;157(12):5411-21.
Auchtung, T. L., et al., Growth hormone response to growth hormone-releasing hormone in beef cows divergently selected for milk production, J Anim Sci., May 2001;79(5):1295-300.
Babiuk, L. A., et al., Induction of immune responses by DNA vaccines in large animals, Vaccine, Jan. 30. 2003;21 (7-8):649-58.
Blethen, S. L., et al., Slipped capital femoral epiphysis in children treated with growth hormone. A summary of the National Cooperative Growth Study experience, Horm Res., 1996;46(3):113-6.
Boguszewski, C. L, et al., One year of GH replacement therapy with a fixed low-dose regimen improves body composition, bone mineral density and lipid profile of GH-deficient adults, Eur J Endocrinol., Jan. 2005;152(1):67-75.
Bohlen, P., et al., Isolation and characterization of the porcine hypothalamic growth hormone releasing factor, Biochem Biophys Res Commun., Oct. 31, 1983;116(2):726-34.
Bollerslev, J., et al., Low-dose GH improves exercise capacity in adults with GH deficiency: effects of a 22-month placebo-controlled, crossover trial, Eur J Endocrinol., Sep. 2005;153(3):379-87.
Boshart, M., et al., A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus, Cell, Jun. 1985;41(2):521-30.
Bramnert, M., et al., Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle, J Clin Endocrinol Metab., Apr. 2003;88(4):1455-63.
Brown, P. A., et al., Immune-enhancing effects of growth hormone-releasing hormone delivered by plasmid injection and electroporation, Mol Ther., Oct. 2004;10(4):644-51.
Carbonelli, D. L., et al., A plasmid vector for isolation of strong promoters inEscherichia coli, FEMS Microbiol Lett., Aug. 1, 1999;177(1):75-82.
Ceda, G. P., et al., The growth hormone (GH)-releasing hormone (GHRH)-GH-somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II, Endocrinology, Apr. 1987;120 (4):1658-62.
Chandler, S. D., et al., RNA splicing specificity determined by the coordinated action of RNA recognition motifs in SR proteins, Proc Natl Acad Sci U S A., Apr. 15, 1997;94(8):3596-601.
Chauhan, S., et al., Fan beam dual energy X-ray absorptiometry body composition measurements in piglets, J Am Coll Nutr., Oct. 2003;22(5):408-14.
Chevalier, R. L., et al., Renal tubulointerstitial injury from ureteral obstruction in the neonatal rat is attenuated by IGF-1, Kidney Int., Mar. 2000;57(3):882-90.
Chung, C. S., et al., Stimulation of swine growth by porcine growth hormone, J Anim Sci., Jan. 1985;60(1):118-30.
Clark, R. G., et al., Growth hormone (GH) secretion in the conscious rat: negative feedback of GH on its own release, J Endocrinol., Nov. 1988;119(2):201-9.
Clark, R. G., et al., Growth induced by pulsatile infusion of an amidated fragment of human growth hormone releasing factor in normal and GHRF-deficient rats, Nature, Mar. 21-27, 1985;314(6008):281-3.
Cocea, L., Duplication of a region in the multiple cloning site of a plasmid vector to enhance cloning-mediated addition of restriction sites to a DNA fragment, Biotechniques, Nov. 1997;23(5):814-6.
Colao, A., et al., Impaired cardiac performance in elderly patients with growth hormone deficiency, J Clin Endocrinol Metab., Nov. 1999;84(11):3950-5.
Colao, et al., Beginning to end: Cardiovascular implications of growth hormone (GH) deficiency and GH therapy, Growth Hormone & IGF Research, Jul. 2006;16(1):41-48.
Cummings, D. E., et al., Age-related changes in growth hormone secretion: should the somatopause be treated?, Semin Reprod Endocrinol., 1999;17(4):311-25.
Dahl, G. E., et al., Comparison of somatotropin and growth hormone-releasing factor on milk yield, serum hormones, and energy status, J Dairy Sci., Oct. 1991;74(10):3421-8.
Dai, B., et al., Identification of a novel cis element required for cell density-dependent down-regulation of insulin-like growth factor-2 P3 promoter activity in Caco2 cells, J Biol Chem., Mar. 9, 2001;276(10):6937-44.
Danko, I., et al., Direct gene transfer into muscle, Vaccine, Dec. 1994;12(16):1499-502.
Darquet, A. M., et al., A new DNA vehicle for nonviral gene delivery: supercoiled minicircle, Gene Ther., Dec. 1997;4(12):1341-9.
Darquet, A. M., et al., Minicircle: an improved DNA molecule for in vitro and in vivo gene transfer, Gene Ther., Feb. 1999;6(2):209-18.
Davis, H. L., et al., Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression, Hum Gene Ther., Apr. 1993;4(2):151-9.
Dolnik, V., et al., Electromigration behavior of poly-(L-glutamate) conformers in concentrated polyacrylamide gels, Biopolymers., Aug. 1993;33(8):1299-306.
Dornonville De La, Cour, C., et al., Ghrelin treatment reverses the reduction in weight gain and body fat in gastrectomised mice, Gut., Jul. 2005;54(7):907-13.
Dorsch-Hasler, K., et al., A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus, Proc Natl Acad Sci U S A. Dec. 1985;82(24):8325-9.
Draghia-Akli, R., et al., Effects of plasmid-mediated growth hormone releasing hormone supplementation in young, healthy Beagle dogs, J Anim Sci., Sep. 2003;81(9):2301-10.
Draghia-Akli, R., et al., High-efficiency growth hormone-releasing hormone plasmid vector administration into skeletal muscle mediated by electroporation in pigs, FASEB J. Mar. 2003;17(3):526-8.
Draghia-Akli, R., et al., A new plasmid-mediated
Draghia-Akli Ruxandra
Fiorroto Marta L.
Khan Amir S.
Kaushal Sumesh
Kim Thomas
VGX Pharmaceuticals, Inc.
LandOfFree
Growth hormone releasing hormone treatment to decrease... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Growth hormone releasing hormone treatment to decrease..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Growth hormone releasing hormone treatment to decrease... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4300490